![]() |
市場調查報告書
商品編碼
1746933
日本輔助生殖技術市場報告(按產品、類型(體外受精、人工授精)、最終用途和地區)2025-2033Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2025-2033 |
2024年,日本輔助生殖技術市場規模達35.247億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到63.29億美元,2025-2033年期間的複合年成長率(CAGR)為6.7%。日本不孕症盛行率的上升、政府推出的支持措施、輔助生殖技術(ART)的近期技術進步,以及社會對不孕症治療的認知度和接受度的提高,是推動市場發展的一些關鍵因素。
輔助生殖技術 (ART) 是指主要用於治療不孕症的醫療程序。它涵蓋多種方法,例如體外受精 (IVF)、卵胞漿內單一精子注射 (ICSI)、配子或胚胎冷凍保存以及生育藥物治療。 ART 具有許多優勢,例如能夠繞過受精過程中的生理障礙、提高配子品質或維持生育能力。它融合了醫學專業知識、先進的實驗室、法律框架和倫理管理。 ART 被不孕夫婦、單身人士以及渴望成為父母的男女同性戀群體廣泛使用。此外,它還可用於預防遺傳性疾病、平衡家庭關係、促進代孕以及癌症患者的生育能力保存。 ART 可以提高受孕幾率、控制受孕時機、篩檢遺傳疾病,並增進人們對自身生育能力的了解。除此之外,它還提供了許多優勢,例如多次懷孕的選擇以及允許同性伴侶或單親父母懷孕。
由於生活方式的改變和老齡人口的增加,日本不孕症的盛行率不斷上升,這是推動市場成長的關鍵因素之一。此外,政府推出的支持措施,例如補貼輔助生殖技術(ART)以鼓勵夫妻尋求治療,也正在推動市場成長。此外,輔助生殖技術(ART)的最新技術進步提高了成功率,從而促進了其應用,也催化了市場成長。此外,社會對不孕症治療的認知和接受度不斷提高,也促進了市場成長。此外,監管框架的持續改進為潛在患者提供了安全保障,也推動了市場成長。此外,日本可支配收入的增加,使更多人能夠負擔得起通常昂貴的輔助生殖技術(ART)等治療,這也促進了市場成長。此外,主要參與者不斷增加對研發和創新的投資,以開發有效的不孕症治療方案,也對市場成長產生了正面影響。此外,日本和國際生育診所之間日益增多的合作,旨在擴大最佳實踐和先進治療手段的可及性,也支持了市場成長。同時,日本文化中日益成長的社會壓力和家庭創造慾望正在推動市場成長。此外,生育旅遊的興起,使人們能夠前往日本享受高品質的輔助生殖技術 (ART) 服務,也刺激了市場成長。此外,輔助生殖技術服務擴展到更廣泛的人群,包括老年女性和單身人士,開闢了新的細分市場,也加速了市場的成長。此外,基因篩檢技術的最新進展使輔助生殖技術更加安全可靠,這也正在加強全國市場的成長。
市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。
Japan assisted reproductive technology market size reached USD 3,524.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,329.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.
Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.
The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.